Clinical Trial Update: Usability of Zubsolv Sublingual Tablets 5.7/1.4 to Suboxone Sublingual Film 8/2 In Buprenorphine/Naloxone Treated Opioid Dependent Population [Phase 4]

View source ↗

Summary

Phase 4 trial evaluated the usability of Zubsolv Sublingual Tablets (buprenorphine/naloxone) compared with Suboxone Sublingual Film (buprenorphine/naloxone) in …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence

Drugs mentioned

• Suboxone Sublingual Film (buprenorphine-naloxone)
• ZUBSOLV (Buprenorphine hydrochloride and naloxone hydrochloride)

Snippet

Sponsor: Indivior Inc. | Conditions: Opioid Dependence | Phase 4 | Status: COMPLETED | Results posted: 2017-03-21